Stay updated on Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The Locations section has been reorganized: a single Locations heading now appears with the participating states (California, Connecticut, Florida, Georgia, Louisiana, Maryland, New York, North Carolina, Ohio, Pennsylvania, Washington), and per-state 'Locations' subsections were removed.
    Difference
    1%
    Check dated 2025-12-23T20:19:46.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Publications section wording updated to state PubMed-sourced publications are automatically filled, with a new revision note (v3.3.2). The previous description about PubMed data and automatic listing by NCT number has been revised (v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-25T10:36:33.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed the funding/operating-status notice banner from the page, and the NIH Clinical Center operating status message is no longer displayed.
    Difference
    0.3%
    Check dated 2025-11-18T06:52:18.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    No significant changes detected on the page; the NCT02267603 study details for Pembrolizumab in Merkel cell carcinoma remain as published, including the overview and eligibility criteria.
    Difference
    0.3%
    Check dated 2025-11-03T20:42:33.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Update to version v3.2.0 and removal of a specific resource (Cutaneous neuroendocrine carcinoma); addition of an important government-operating status notice and links.
    Difference
    2%
    Check dated 2025-10-06T04:35:14.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.
    Difference
    0.0%
    Check dated 2025-09-29T01:18:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.